Prognostic Factors Determining Long-Term Survival in Well-Differentiated Thyroid Cancer: An Analysis of Four Hundred Eighty-Four Patients Undergoing Therapy and Aftercare at the Same Institution

Thyroid

Volumn 13, Issue 10, 2003, Pages 949-958

  Eichhorn, Waltraud ^a,b   Tabler, Harry ^a   Lippold, Rainer ^a   Lochmann, Matthias ^a   Schreckenberger, Mathias ^a   Bartenstein, Peter ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b Department of Nuclear Medicine ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131; THYROGLOBULIN;

ADOLESCENT; ADULT; AFTERCARE; AGE DISTRIBUTION; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COHORT ANALYSIS; COMORBIDITY; FEMALE; FOLLOW UP; GENDER; HIGH RISK PATIENT; HUMAN; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; REGRESSION ANALYSIS; RISK ASSESSMENT; SURVIVAL RATE; SURVIVAL TIME; THYROID CANCER; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA; THYROIDECTOMY; TUMOR DIFFERENTIATION;

EID: 0242299671     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/105072503322511355     Document Type: Article

References (41)

1. Colonna M, Grosclaude P, Remontet L, Schvartz C, Mace-Lesech J, Velten M, Guizard A, Tretarre B, Buemi AV, Arveux P, Esteve J 2002 Incidence of thyroid cancer in adults recorded by French cancer registries (1978-1997) Eur J Cancer 38:1762-1768.
2. Levi F, Randimbison L, Te VC, La VC 2002 Thyroid cancer in Vaud, Switzerland: an update. Thyroid 12:163-168.
3. DeGroot LJ, Kaplan EL, Straus FH, Shukla MS 1994 Does the method of management of papillary thyroid carcinoma make a difference in outcome? World J Surg 18:123-130.
4. Hay ID, Bergstralh EJ, Grant CS, McIver B, Thompson GB, van Heerden JA, Goellner JR 1999 Impact of primary surgery on outcome in 300 patients with pathologic tumornode-metastasis stage III papillary carcinoma treated at one institution from 1940 through 1989. Surgery 126:1173-1181.
5. Hoelzer S, Steiner D, Bauer R, Reiners C, Farahati J, Hundahl SA, Dudeck J 2000 Current practice of radioiodine treatment in the management of differentiated thyroid cancer in Germany. Eur J Nucl Med 27:1465-1472.
6. Hundahl SA, Cady B, Cunningham MP, Mazzaferri E, McKee RF, Rosai J, Shah JP, Fremgen AM, Stewart AK, Holzer S 2000 Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the united states during 1996. U.S. and German Thyroid Cancer Study Group. An American College of Surgeons Commission on Cancer. Patient Care Evaluation study. Cancer 89:202-217.
7. Saur HB, Lerch H, Schober O 1996 The survival rate of patients with a differentiated thyroid carcinoma without primary percutaneous irradiation of the neck area. Strahlenther Onkol 172:306-311.
8. Schicha H, Dietlein M 1997 Radioiodine therapy in differentiated thyroid gland carcinoma. Zentralbl Chir 122:266-273.
9. Pelizzo MR, Toniato A, Grigoletto R 1997 Surgical treatment of papillary thyroid carcinoma: Uni- and multivariate analysis of prognostic factors (TNM staging system included). J Exp Clin Cancer Res 16:261-265.
10. Benker G, Olbricht T, Reinwein D, Reiners C, Sauerwein W, Krause U, Mlynek ML, Hirche H 1990 Survival rates in patients with differentiated thyroid carcinoma. Influence of postoperative external radiotherapy. Cancer 65:1517-1520.
11. 131I therapy of thyroid cancer patients. J Nucl Med 43:324-335.
12. Mazzaferri EL, Young RL 1981 Papillary thyroid carcinoma: A 10 year follow-up report of the impact of therapy in 576 patients. Am J Med 70:511-518.
13. Tubiana M, Haddad E, Schlumberger M, Hill C, Rougier P, Sarrazin D 1985 External radiotherapy in thyroid cancers. Cancer 55(suppl)2062-2071.
14. Sobin LH, Wittekind C (eds) TNM Classification of Malignant Tumors, 5th ed. John Wiley & Sons, New York, 1997.
15. Lerch H, Schober O, Kuwert T, Saur HB 1997 Survival of differentiated thyroid carcinoma studied in 500 patients. J Clin Oncol 15:2067-2075.
16. Sophocleous S, Ehrenheim C, Fischer J, Hundeshagen H. 1997 Low-risk thyroid carcinoma-Therapy, follow-up and prognosis Nuklearmedizin 36:93-102.
17. Wittekind C, Meyer H-J, Bootz F (eds) TNM Classification of Malignant Tumors, 6th ed. Wiley-Liss, New York, 2002.
18. Görges R, Brandt-Mainz K, Freundenberg L, Frilling A, Grimm W, Bockisch A Continously increasing sensitivity in thyroid cancer aftercare in the course of three generations of thyroglobulin IMAs. Nuklearmedizin 42:157-166.
19. Hamming JF, Van de Velde CJ, Goslings BM, Schelfhout LJ, Fleuren GJ, Hermans J, Zwaveling A 1989 Prognosis and morbidity after total thyroidectomy for papillary, follicular and medullary thyroid cancer. Eur J Cancer Clin Oncol 25:1317-1323.
20. Balan KK, Raouf AH, Critchley M 1994 Outcome of 249 patients attending a nuclear medicine department with well differentiated thyroid cancer: A 23 year review. Br J Radiol 67:283-291.
21. Scheumann GF, Gimm O, Wegener G, Hundeshagen H, Dralle H 1994 Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancer. World J Surg 18:559-567.
22. Zidan J, Kassem S, Kuten A 2000 Follicular carcinoma of the thyroid gland: Prognostic factors, treatment, and survival. Am J Clin Oncol 23:1-5.
23. Passler C, Prager G, Scheuba C, Kaserer K, Zettinig G, Niederle B 2003 Application of staging systems for differentiated thyroid carcinoma in an endemic goiter region with iodine substitution. Ann Surg 237:227-234.
24. Tsang RW, Brierley JD, Simpson WJ, Panzarella T, Gospodarowicz MK, Sutcliffe SB 1998 The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma. Cancer 82:375-388.
25. Shaha AR, Loree TR, Shah JP 1995 Prognostic factors and risk group analysis in follicular carcinoma of the thyroid. Surgery 118:1131-1136.
26. Sandrock D, Munz DL 1991 The diagnosis of thyroid carcinoma. Dtsch Med Wochenschr 116:77-78.
27. Klar E, Weber T, Colombo-Benkmann M, Herfarth C 1998 Die chirurgische Therapie des Schilddrüsenkarzinoms. Tumordiagn u Ther 19:64-69.
28. Sartorelli B, Glanzmann C, Lutolf UM 1990 Long-term results following radioiodine treatment of patients with metastasizing follicular and papillary thyroid carcinoma. Schweiz Rundsch Med Prax 79:1523-1530.
29. Loh KC, Greenspan FS, Gee L, Miller TR, Yeo PPB 1997 Pathological tumor-node-metastasis staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients. J Clin Endocrinol Metab 82:3553-3562.
30. Simpson WJ, McKinney SE, Carruthers JS, Gospodarowicz MK, Sutcliffe SB, Panzarella T 1987 Papillary and follicular thyroid cancer. Prognostic factors in 1578 patients. Am J Med 83:479-488.
31. Mazzaferri EL, Jhiang SM 1994 Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 97:418-428.
32. Sellers M, Beenken S, Blankenship A, Soong SJ, Turbat-Herrera E, Urist M, Maddox W 1992 Prognostic significance of cervical lymph node metastases in differentiated thyroid cancer. Am J Surg 164:578-581.
33. Chow SM, Law SC, Mendenhall WM, Au SK, Chan PT, Leung TW, Tong CC, Wong IS, Lau WH 2002 Papillary thyroid carcinoma: Prognostic factors and the role of radioiodine and external radiotherapy. Int J Radiat Oncol Biol Phys 52:784-795.
34. Biermann M, Schober O 2002 Administered 1-131 doses and time until complete ablation of the thyroid remnant before adjuvant percutaneous radiotherapy in the multicenter study differentiated carcinoma (MSDS) [abstract]. J Nucl Med 43(suppl):321p.
35. Machens A, Hinze R, Lautenschlager C, Thomusch O, Dralle H 2001 Prophylactic completion thyroidectomy for differentiated thyroid carcinoma: Prediction of extrathyroidal soft tissue infiltrates. Thyroid 11:381-384.
36. Simon D, Goretzki PE, Witte J, Roher HD 1996 Incidence of regional recurrence guiding radicality in differentiated thyroid carcinoma. World J Surg 20:860-866.
37. Noguchi M, Kumaki T, Taniya T, Miyazaki I 1990 Bilateral cervical lymph node metastases in well-differentiated thyroid cancer. Arch Surg 125:804-806.
38. Noguchi M, Kumaki T, Taniya T, Segawa M, Nakano T, Ohta N, Miyazaki I 1990 Impact of neck dissection on survival in well-differentiated thyroid cancer: A multivariate analysis of 218 cases. Int Surg 75:220-224.
39. Gemsenjäger E, Heitz PU, Martina B, Schweizer I 2002 Differentiated thyroid carcinoma. Surgery and significance of lymph node involvement. Chirurg 73:38-43.
40. Yamashita H, Noguchi S, Yamashita H, Murakami N, Watanabe S, Uchino S, Kawamoto H, Toda M, Nakayama I 1998 Changing trends and prognoses for patients with papillary thyroid cancer. Arch Surg 133:1058-1065.
41. Lees W, Mansberg R, Roberts J, Towson J, Chua E, Turtle J 2002 The clinical effects of thyroid stunning after diagnostic whole-body scanning with 185 MBq 131-I. Eur J Nucl Med Mol Imaging 29:1421-1427.